These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 715249)

  • 1. [Pentaerythritol "forte" in the treatment of coronary disease (author's transl)].
    Kawecka-Jaszcz K; Kocemba J; Moczurad K; Wójcikiewiczowa O
    Przegl Lek; 1978; 35(8):675-8. PubMed ID: 715249
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of "pentrium", drug improving coronary circulation].
    Wasyluk J; Ruźyllo E
    Pol Tyg Lek; 1966 Nov; 21(48):1853-4. PubMed ID: 5979531
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR; Zanacchi G
    Minerva Cardioangiol; 1971 Mar; 19(3):160-71. PubMed ID: 4396512
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of Peritrate in acute coronary insufficiency].
    Tricot R; Valère P; Castillo A
    Therapeutique; 1971 Nov; 47(9):777-8. PubMed ID: 4947933
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new 2-phase coronary agent for the treatment of angina pectoris due to coronary disease].
    Gill E
    Med Welt; 1978 Mar; 29(10):408-11. PubMed ID: 416316
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study on therapeutic efficacy of 2-benzofuryl-p-chlorophenyl carbinol (Clobenfurol) alone or in association with pentaerythritol tetranitrate].
    Martinelli M; Villecco A
    Minerva Cardioangiol; 1973 Jan; 21(1):60-6. PubMed ID: 4572004
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pentaerythritol tetranitrate effects on electrocardiographic changes induced by glucose loading].
    Ferlito S; Bonaventura S
    Policlinico Med; 1971; 78(6):252-62. PubMed ID: 5157399
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrolyte therapy of coronary insufficiency in the practice].
    Menzel M
    Landarzt; 1968 Jul; 44(20):993-5. PubMed ID: 5717732
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
    Ballerini A
    Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of pentaerithrol and raupasil on nasal patency].
    Kubiak S; Hauslinger J
    Pol Tyg Lek; 1977 Jan; 32(2):57-9. PubMed ID: 834635
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience with the coronary therapeutic agent STENO-Tromcardin in the general practice].
    Jaschke J
    Med Welt; 1969 Mar; 13():744-6. PubMed ID: 5784357
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the objective evaluation of the effects of coronary vasoactive drugs].
    Lenti G; Cherchi A; Raffo M; Porrazzo G
    Minerva Med; 1966 Feb; 57(12):455-9. PubMed ID: 5910815
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coronary therapy with Nitro-Sandolanid].
    Toker Y
    Munch Med Wochenschr; 1970 Apr; 112(17):809-12. PubMed ID: 5467991
    [No Abstract]   [Full Text] [Related]  

  • 18. [The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
    Guglielmi G; Barlattani M
    Clin Ter; 1971 Aug; 58(3):229-42. PubMed ID: 5135002
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial].
    Di Prisco AU; Vaccari GL; Soro A; Mora A
    Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
    Borroni G
    Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.